apomorphine has been researched along with remoxipride in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlsson, A; Hansson, L; Lin, CH; Smith, MW; Sonesson, C; Svensson, K; Waters, N; Wikström, H | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fuxe, K; Ogren, SO | 1 |
| Demenge, P; Pellissier, G | 1 |
| Bertorelli, R; Consolo, S | 1 |
| de Paulis, T; Hall, H; Högberg, T; Johansson, L; Kumar, Y; Ogren, SO | 1 |
| Florvall, L; Hall, H; Köhler, C; Magnusson, O; Ogren, SO | 1 |
| Hall, H; Jerning, E; Sällemark, M | 1 |
| Ljungberg, T; Ogren, SO; Rodebjer, A; Ståhle, L; Ungerstedt, U | 1 |
| Angeby, K; Florvall, L; Hall, H; Köhler, C; Lindbom, LO; Magnusson, O; Ogren, SO | 1 |
| Angeby-Möller, K; Hall, H; Ogren, SO; Widman, M | 1 |
| Lawler, CP; Mailman, RB; Nichols, DE; Smith, HP | 1 |
| Kulla, A; Manahan-Vaughan, D | 1 |
| Cools, AR; Ellenbroek, BA; van der Elst, MC; Wunderink, YS | 1 |
17 other study(ies) available for apomorphine and remoxipride
| Article | Year |
|---|---|
Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships.
Topics: Animals; Benzazepines; Brain; CHO Cells; Cricetinae; Dihydroxyphenylalanine; Dopamine D2 Receptor Antagonists; Habituation, Psychophysiologic; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Molecular Structure; Motor Activity; Optical Rotation; Piperidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Serotonin; Reserpine; Serotonin Antagonists; Spiperone; Structure-Activity Relationship; Transfection | 1994 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The unique effect of remoxipride on dopamine utilization in the basal ganglia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Basal Ganglia; Benzamides; Caudate Nucleus; Dopamine; Male; Motor Activity; Nucleus Accumbens; Olfactory Bulb; Putamen; Rats; Rats, Inbred Strains; Remoxipride; Stereotyped Behavior | 1991 |
Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia; Animals; Antipsychotic Agents; Apomorphine; Benzamides; Benzazepines; Blood Pressure; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Fenoldopam; Heart Rate; Injections, Spinal; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Spinal Cord | 1991 |
D1 and D2 dopaminergic regulation of acetylcholine release from striata of freely moving rats.
Topics: Acetylcholine; Animals; Apomorphine; Benzamides; Benzazepines; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Ergolines; Female; In Vitro Techniques; Motor Activity; Quinpirole; Rats; Rats, Inbred Strains; Remoxipride | 1990 |
Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine Antagonists; Hydrogen Bonding; Male; Molecular Structure; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Remoxipride; Salicylamides; Spiperone; Structure-Activity Relationship | 1990 |
[Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Catalepsy; Chemical Phenomena; Chemistry; Dopamine; Male; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Stereotyped Behavior | 1985 |
Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Benzamides; Brain; Domperidone; Dopamine; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Salicylamides; Spiperone; Structure-Activity Relationship; Tetrahydronaphthalenes; Tritium | 1986 |
Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the rat.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Dopamine Antagonists; Exploratory Behavior; Male; Motor Activity; Rats; Rats, Inbred Strains; Remoxipride; Stereotyped Behavior | 1987 |
Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Binding, Competitive; Brain Chemistry; Catalepsy; Chlorpromazine; Dogs; Female; Haloperidol; Histocytochemistry; Humans; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Spiperone; Sulpiride; Thioridazine; Vomiting | 1984 |
Effects of remoxipride's metabolites on dopamine D2 receptors and receptor functions in the rat.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Hypothermia; In Vitro Techniques; Male; Motor Activity; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride | 1993 |
Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Apomorphine; Benzazepines; Computer Simulation; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Idazoxan; Locomotion; Male; Mastication; Phenanthridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Reference Standards; Remoxipride; Stereoisomerism; Yawning | 1997 |
Regulation of depotentiation and long-term potentiation in the dentate gyrus of freely moving rats by dopamine D2-like receptors.
Topics: Animals; Apomorphine; Dentate Gyrus; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electrophysiology; Evoked Potentials; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Neuronal Plasticity; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Remoxipride; Synaptic Transmission | 2003 |
Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Apomorphine; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Inhibition, Psychological; Injections, Intraperitoneal; Male; Neurons; Rats; Rats, Inbred Strains; Reflex, Startle; Remoxipride; Reserpine; Schizophrenic Psychology | 2007 |